Date of event: date of event was approximated to (b)(6) 2011 (implant date) as no event date was reported.The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Patient's additional lawyers: (b)(6).The device was implanted at (b)(6), by dr.(b)(6).(b)(4).The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
It was reported to boston scientific corporation that a solyx sis system was implanted during a procedure performed on (b)(6) 2011 to treat stress urinary incontinence, uterine prolapse, cystocele, and rectocele.As per reported by the patient's attorney, the patient has a negative response to the implanted device that promotes inflammation of the pelvic tissue and contributes to the formation of severe adverse reactions to the mesh.After the procedure, the patient experienced pain, development of bladder stones, and mesh erosion; consequently requiring several mesh removal and reparative surgeries.The patient has to undergo operations to locate and remove mesh, and operations to attempt to repair pelvic organs, tissue, and nerve damage.Additionally, she has to use pain control and other medications, and injections into various areas of the pelvis, spine, and the vagina.The patient also has to undergo operations to remove portions of the female genitalia.These surgical treatments and attendant medical care were performed at a different healthcare facility on (b)(4) 2018.Reportedly, as a result of the device implantation, the patient has experienced significant mental and physical pain and suffering, has sustained permanent injury, has undergone medical treatment and will likely undergo further medical treatment and procedures.
|